Works matching IS 2160763X AND DT 2018 AND VI 7 AND IP 1
Results: 13
Cardiac Safety of Rupatadine in a Single-Ascending-Dose and Multiple-Ascending-Dose Study in Healthy Japanese Subjects, Using Intensive Electrocardiogram Assessments-Comparison With the Previous White Caucasian Thorough QT Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 67, doi. 10.1002/cpdd.370
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 1, doi. 10.1002/cpdd.398
- Publication type:
- Article
Single- and Multiple-Day Dosing Studies to Investigate High-Dose Pharmacokinetics of Epelsiban and Its Metabolite, GSK2395448, in Healthy Female Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 33, doi. 10.1002/cpdd.363
- By:
- Publication type:
- Article
Evaluation of a 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation: A Randomized, 3-Way Crossover Pharmacokinetic and Safety Study in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 95, doi. 10.1002/cpdd.367
- By:
- Publication type:
- Article
Selection of 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained-Release Prototype Formulations and Standard Acetaminophen Formulation: An Open-Label, Randomized, Proof-of-Principle Pharmacokinetic Study
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 87, doi. 10.1002/cpdd.368
- By:
- Publication type:
- Article
Bioequivalence and Safety of Twice-Daily Sustained-Release Paracetamol (Acetaminophen) Compared With 3- and 4-Times-Daily Paracetamol: A Repeat-Dose, Crossover Pharmacokinetic Study in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 77, doi. 10.1002/cpdd.369
- By:
- Publication type:
- Article
Opioid Prescribing: What Are the Numbers?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Announcement.
- Published in:
- 2018
- By:
- Publication type:
- Other
Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 9, doi. 10.1002/cpdd.388
- By:
- Publication type:
- Article
Acid Inhibitory Effect of a Combination of Omeprazole and Sodium Bicarbonate (CDFR0209) Compared With Delayed-Release Omeprazole 40 mg Alone in Healthy Adult Male Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 53, doi. 10.1002/cpdd.331
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability Following Single and Multiple Doses of Pibrentasvir in a First-in-Human Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 44, doi. 10.1002/cpdd.350
- By:
- Publication type:
- Article
Randomized, Blinded, Placebo- and Positive-Controlled Crossover Study to Determine the Effect of Deferiprone on the QTc Interval in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 22, doi. 10.1002/cpdd.352
- By:
- Publication type:
- Article
A Phase 1 Randomized, Placebo-Controlled Study Assessing the Pharmacokinetics, Safety, and Tolerability of Retosiban in Healthy, Nonpregnant Japanese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 59, doi. 10.1002/cpdd.355
- By:
- Publication type:
- Article